Search filters

List of works by Taro Kishi

A functional polymorphism in estrogen receptor alpha gene is associated with Japanese methamphetamine induced psychosis

scientific article published on 19 April 2009

A single-nucleotide polymorphism influences brain morphology in drug-naïve patients with major depressive disorder

scientific article published on 23 August 2019

Alpha4 and beta2 subunits of neuronal nicotinic acetylcholine receptor genes are not associated with methamphetamine-use disorder in the Japanese population

scientific article

An evaluation of polymorphisms in casein kinase 1 delta and epsilon genes in major psychiatric disorders

scientific article published on 7 September 2012

Aripiprazole vs. brexpiprazole for acute schizophrenia: a systematic review and network meta-analysis

scientific article published on 30 January 2020

Association analysis of GRM2 and HTR2A with methamphetamine-induced psychosis and schizophrenia in the Japanese population

scientific article published on 6 March 2010

Association analysis of SIGMAR1 with major depressive disorder and SSRI response

scientific article published on 21 February 2010

Association analysis of functional polymorphism in estrogen receptor alpha gene with schizophrenia and mood disorders in the Japanese population

scientific article published in August 2009

Association analysis of group II metabotropic glutamate receptor genes (GRM2 and GRM3) with mood disorders and fluvoxamine response in a Japanese population

scientific article published on 19 April 2009

Association analysis of nuclear receptor Rev-erb alpha gene (NR1D1) with mood disorders in the Japanese population

scientific article published on 30 August 2008

Association between discontinuation due to withdrawal of consent and use of long-acting injectable antipsychotics: A meta-analysis of randomized trials for schizophrenia

scientific article published on 16 October 2020

Association of Serum Kynurenine Levels and Neural Networks in Patients with First-Episode, Drug-Naïve Major Depression: A Source-Based Morphometry Study

scientific article published on 29 October 2020

Association study of clock gene (CLOCK) and schizophrenia and mood disorders in the Japanese population

scientific article published on 17 February 2009

BDNF is not associated with schizophrenia: data from a Japanese population study and meta-analysis

scientific article

CLOCK may predict the response to fluvoxamine treatment in Japanese major depressive disorder patients

scientific article

COMT Val158Met, but not BDNF Val66Met, is associated with white matter abnormalities of the temporal lobe in patients with first-episode, treatment-naïve major depressive disorder: a diffusion tensor imaging study

scientific article

COMT polymorphism regulates the hippocampal subfield volumes in first-episode, drug-naive patients with major depressive disorder.

scientific article published on 6 June 2019

Comparison of the efficacy and safety of 4 and 2 mg/day brexpiprazole for acute schizophrenia: a meta-analysis of double-blind, randomized placebo-controlled trials

scientific article published on 01 October 2018

Comparison of the efficacy between paroxetine and sertraline augmented with aripiprazole in patients with refractory major depressive disorder

scientific article published on 17 July 2012

Copy number variation in schizophrenia in the Japanese population

scientific article

Duration of untreated illness and antidepressant fluvoxamine response in major depressive disorder

scientific article published on June 2010

Efficacy and safety of lithium and lamotrigine for the maintenance treatment of clinically stable patients with bipolar disorder: A systematic review and meta-analysis of double-blind, randomized, placebo-controlled trials with an enrichment design

scientific article published on 26 April 2019

Efficacy, tolerability, and safety of lurasidone for acute schizophrenia: A systematic review and network meta-analysis of phase 3 trials in Japan

scientific article published on 07 August 2020

Failure to replicate the association between NRG1 and schizophrenia using Japanese large sample

scientific article published on 20 February 2008

Folic acid/methylfolate for the treatment of psychopathology in schizophrenia: a systematic review and meta-analysis

scientific article published on 22 May 2018

Further evidence of an association between a genetic variant in BMP7 and treatment response to SSRIs in major depressive disorder

scientific article

GTP cyclohydrolase 1 gene haplotypes as predictors of SSRI response in Japanese patients with major depressive disorder

scientific article published on 6 July 2012

Genetic association analysis of NRG1 with methamphetamine-induced psychosis in a Japanese population.

scientific article published on 24 April 2009

Genetic association analysis of functional polymorphisms in neuronal nitric oxide synthase 1 gene (NOS1) and mood disorders and fluvoxamine response in major depressive disorder in the Japanese population

scientific article published on 12 December 2009

Genetic association analysis of serotonin 2A receptor gene (HTR2A) with bipolar disorder and major depressive disorder in the Japanese population

scientific article

Genetic association analysis of tagging SNPs in alpha4 and beta2 subunits of neuronal nicotinic acetylcholine receptor genes (CHRNA4 and CHRNB2) with schizophrenia in the Japanese population

scientific article published on 2 September 2008

Genetic effects on white matter integrity in drug-naive patients with major depressive disorder: a diffusion tensor imaging study of 17 genetic loci associated with depressive symptoms

scientific article published on 29 January 2019

Genome-wide association study of schizophrenia in a Japanese population

scientific article published on 15 September 2010

Glutamate cysteine ligase modifier (GCLM) subunit gene is not associated with methamphetamine-use disorder or schizophrenia in the Japanese population

scientific article

HTR2A is associated with SSRI response in major depressive disorder in a Japanese cohort

scientific article published on 24 November 2009

Lack of association between MAGEL2 and schizophrenia and mood disorders in the Japanese population

scientific article published on 14 May 2010

Lack of association between prokineticin 2 gene and Japanese methamphetamine dependence.

scientific article

Lack of association between translin-associated factor X gene (TSNAX) and methamphetamine dependence in the Japanese population

scientific article published on 13 June 2011

Lurasidone, olanzapine, and quetiapine extended-release for bipolar depression: A systematic review and network meta-analysis of phase 3 trials in Japan

scientific article published on 09 September 2020

Melatonin receptor agonists-ramelteon and melatonin-for bipolar disorder: a systematic review and meta-analysis of double-blind, randomized, placebo-controlled trials.

scientific article published on 30 May 2019

Memantine treatment for Japanese patients with moderate to severe Alzheimer’s disease: a meta-analysis of double-blind, randomized, placebo-controlled trials

scientific article published on 30 October 2018

Meta-analysis of association between genetic variants in COMT and schizophrenia: an update

scientific article published on 28 March 2009

Mood stabilizers and/or antipsychotics for bipolar disorder in the maintenance phase: a systematic review and network meta-analysis of randomized controlled trials

scientific article published on 11 November 2020

N-acetylcysteine as an adjunctive treatment for bipolar depression and major depressive disorder: a systematic review and meta-analysis of double-blind, randomized placebo-controlled trials

scientific article published on 06 August 2020

No Association Between GRM3 and Japanese Methamphetamine-Induced Psychosis.

scientific article

No Association between the Response to the Addition of an Atypical Antipsychotic Drug to an SSRI or SNRI and the BDNF (Val66Met) Polymorphism in Refractory Major Depressive Disorder in Japanese Patients

scientific article published on 30 April 2012

No association between BDNF Val66Met polymorphism and emergence of psychiatric symptoms in systemic lupus erythematosus patients

scientific article published on June 16, 2011

No association between polymorphisms of neuronal oxide synthase 1 gene (NOS1) and schizophrenia in a Japanese population.

scientific article

No association between prostate apoptosis response 4 gene (PAWR) in schizophrenia and mood disorders in a Japanese population

scientific article

No association between tagging SNPs of SNARE complex genes (STX1A, VAMP2 and SNAP25) and schizophrenia in a Japanese population

scientific article published on 01 October 2008

No association of complexin1 and complexin2 genes with schizophrenia in a Japanese population

scientific article published on 25 January 2006

No significant association between SIRT1 gene and methamphetamine-induced psychosis in the Japanese population

scientific article published on 31 August 2011

No significant association between brain-derived neurotrophic factor gene rs6265 and cognitive function in Japanese patients with schizophrenia.

scientific article

Orphan nuclear receptor Rev-erb alpha gene (NR1D1) and fluvoxamine response in major depressive disorder in the Japanese population.

scientific article published on 2 July 2009

PROKR2 is associated with methamphetamine dependence in the Japanese population

scientific article published on 24 May 2010

Paliperidone palmitate vs. paliperidone extended-release for the acute treatment of adults with schizophrenia: a systematic review and pairwise and network meta-analysis

scientific article published in 2022

Pharmacogenetic study of serotonin 6 receptor gene with antidepressant response in major depressive disorder in the Japanese population

scientific article published on August 2010

Plasma levels of IL-6 in patients with untreated major depressive disorder: comparison with catecholamine metabolites

scientific article published on 13 September 2019

Possible association between ubiquitin-specific peptidase 46 gene and major depressive disorders in the Japanese population

scientific article published on 12 June 2011

Possible association of prokineticin 2 receptor gene (PROKR2) with mood disorders in the Japanese population

scientific article published on 20 June 2009

Prostate apoptosis response 4 gene is not associated with methamphetamine-use disorder in the Japanese population

scientific article

Quetiapine extended-release vs olanzapine for Japanese patients with bipolar depression: A Bayesian analysis

scientific article published on 08 July 2019

Recurrence rates in stable bipolar disorder patients after drug discontinuation v. drug maintenance: a systematic review and meta-analysis

scientific article published on 13 October 2020

Relationship between G1287A of the NET Gene Polymorphisms and Brain Volume in Major Depressive Disorder: A Voxel-Based MRI Study

scientific article

Relationship between a BDNF gene polymorphism and the brain volume in treatment-naive patients with major depressive disorder: A VBM analysis of brain MRI.

scientific article published on 30 May 2015

Response to the Letter from Dr. Jacob Peedicayil

scientific article published on 05 December 2018

Response to the letter from Dr. Veerman and colleagues.

scientific article published on 7 October 2017

SIRT1 gene is associated with major depressive disorder in the Japanese population

scientific article published on 7 May 2010

Serotonin 1A receptor gene and major depressive disorder: an association study and meta-analysis

scientific article published on 4 September 2009

Serotonin 1A receptor gene is associated with Japanese methamphetamine-induced psychosis patients

scientific article published on 10 September 2009

Serotonin 1A receptor gene, schizophrenia and bipolar disorder: an association study and meta-analysis

scientific article published on 01 July 2010

Serotonin 6 receptor gene and mood disorders: case-control study and meta-analysis

scientific article published on 13 April 2010

Serotonin 6 receptor gene and schizophrenia: case-control study and meta-analysis

scientific article published in January 2012

Serotonin 6 receptor gene is associated with methamphetamine-induced psychosis in a Japanese population

scientific article published on 11 August 2010

Serum Levels of Brain-Derived Neurotrophic Factor at 4 Weeks and Response to Treatment with SSRIs.

scientific article published on 21 January 2014

Serum levels of brain-derived neurotrophic factor (BDNF), BDNF gene Val66Met polymorphism, or plasma catecholamine metabolites, and response to mirtazapine in Japanese patients with major depressive disorder (MDD)

scientific article published on August 10, 2012

Serum proBDNF/BDNF and response to fluvoxamine in drug-naïve first-episode major depressive disorder patients.

scientific article

Suvorexant for insomnia in patients with psychiatric disorder: A 1-week, open-label study

scientific article published on 08 July 2019

The CLOCK gene and mood disorders: a case-control study and meta-analysis

scientific article published in November 2011

The brain-derived neurotrophic factor (BDNF) polymorphism Val66Met is associated with neither serum BDNF level nor response to selective serotonin reuptake inhibitors in depressed Japanese patients

scientific article published on 19 February 2011

The serotonin 1A receptor gene confer susceptibility to mood disorders: results from an extended meta-analysis of patients with major depression and bipolar disorder

scientific article published on 03 July 2012

Three polymorphisms of the eNOS gene and plasma levels of metabolites of nitric oxide in depressed Japanese patients: a preliminary report

scientific article published in October 2011

Translin-associated factor X gene (TSNAX) may be associated with female major depressive disorder in the Japanese population

scientific article published on 4 September 2009

Vortioxetine vs placebo in major depressive disorder: A systematic review and meta-analysis of double-blind, randomized, placebo-controlled, phase 3 trials in Japan

scientific article published on 16 March 2020

Walking intervention and dietary guidance efficacy for overweight people with schizophrenia: An open‐label 12‐week study

scientific article published in 2022